Article
Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.
International journal of cancer - 20 Jan 2004
Kadouri Luna, Kote-Jarai Zsofia, Easton Douglas F, Hubert Ayala, Hamoudi Rifat, Glaser Benjamin, Abeliovich Dvorah, Peretz Tamar, Eeles Rosalind A
Abstract excerpt
Variation in the penetrance estimates for BRCA1 and BRCA2 mutation carriers suggests that other factors may modify cancer risk from specific mutations. One possible mechanism is an epigenetic effect of polymorphisms in other genes. Genes involved in hormonal signal transduction are possible candidates. The AIB1 gene, an estrogen receptor (ER) coactivator, is frequently amplified in breast and ovarian tumors....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
